FEEL SAFE
WITH YOUR HearO™
BY YOUR SIDE

Using only the patient speech, sampled via mobile device, Cordio HearO™ can sense fluid accumulation related to CHF and alert prior to hospitalization. The HearO™ is the first easy to use, non-invasive, medical grade CHF monitoring device that patients actually want to use!
patient

Patient’s voice is captured by the smartphone app/voice based digital assistance and sent for analysis

cordiomed
cordiomed
patient

A real-time speech/voice analysis workflow detects early buildup of fluids in the patient’s lungs before the appearance of clinical symptoms

cordiomed
cordiomed
patient

Notices are generated once a deviation from the patient pre-defined baseline

logo

HOW IT WORKS

During monitoring, samples of the patient’s speech are analyzed and compared to our proven baseline created on a per patient basis, measuring specific differences which may signal a risk to the patient’s health. Once identified, HCPs are immediately informed and life-saving measures can be taken in real time.

The HearO™ uses the patient’s speech, to create a patient-specific and adaptive model, detecting differences which are characteristic of the target disorder and can lead to hospitalization/ deterioration. Ultimately, the HearO™ can significantly reduce the need for additional hospitalization due to complications of CHF that can be remedied if addressed in a timely manner.

PERSONALIZED MEDICINE

Technology has opened the doors for personalized medicine, offering dedicated monitoring, treatment options and support to a patient’s individual needs. This practice has taken patient care to a new level, not only by saving more lives but also by drastically improving patients’ quality of life.

Personal Medicine